UA127451C2 - Штам streptomyces fungicidicus для продукування ендурацидину та спосіб одержання ендурацидину - Google Patents
Штам streptomyces fungicidicus для продукування ендурацидину та спосіб одержання ендурацидину Download PDFInfo
- Publication number
- UA127451C2 UA127451C2 UAA201906560A UAA201906560A UA127451C2 UA 127451 C2 UA127451 C2 UA 127451C2 UA A201906560 A UAA201906560 A UA A201906560A UA A201906560 A UAA201906560 A UA A201906560A UA 127451 C2 UA127451 C2 UA 127451C2
- Authority
- UA
- Ukraine
- Prior art keywords
- enduracidin
- amino acid
- strain
- dna
- protein
- Prior art date
Links
- 241000971005 Streptomyces fungicidicus Species 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 claims abstract description 25
- 239000001963 growth medium Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 11
- 238000002955 isolation Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 description 74
- 125000003275 alpha amino acid group Chemical group 0.000 description 47
- 235000018102 proteins Nutrition 0.000 description 42
- 102000004169 proteins and genes Human genes 0.000 description 42
- 108020004414 DNA Proteins 0.000 description 37
- 230000035772 mutation Effects 0.000 description 27
- 108700026244 Open Reading Frames Proteins 0.000 description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 17
- 238000000855 fermentation Methods 0.000 description 14
- 230000004151 fermentation Effects 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- NJCUSQKMYNTYOW-MWUYRYRWSA-N enramicina Chemical compound O.N1C(=O)NC(=O)C(C=2C=C(Cl)C(O)=C(Cl)C=2)NC(=O)C(CO)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(CC2N=C(N)NC2)NC(=O)C(CCCNC(N)=O)NC(=O)C(C(C)O)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C(C)O)NC(=O)N(CCCCN)C(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(NC(=O)C(CC(O)=O)NC(=O)/C=C/C=C/CCCCC(C)CC)C(C)OC(=O)C(C=2C=CC(O)=CC=2)NC(=O)C(C)NC(=O)C1CC1CNC(N)=N1 NJCUSQKMYNTYOW-MWUYRYRWSA-N 0.000 description 13
- 108700041171 enramycin Proteins 0.000 description 13
- 229950003984 enramycin Drugs 0.000 description 13
- 239000002773 nucleotide Substances 0.000 description 13
- 125000003729 nucleotide group Chemical group 0.000 description 13
- 229920001184 polypeptide Polymers 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- 244000005700 microbiome Species 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 108091008053 gene clusters Proteins 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 238000005273 aeration Methods 0.000 description 7
- 210000000349 chromosome Anatomy 0.000 description 7
- 238000012217 deletion Methods 0.000 description 7
- 230000037430 deletion Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000037433 frameshift Effects 0.000 description 7
- 230000001965 increasing effect Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 230000008827 biological function Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 231100000221 frame shift mutation induction Toxicity 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 229930014626 natural product Natural products 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 230000037361 pathway Effects 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 101100049050 Arabidopsis thaliana PVA41 gene Proteins 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 108700005075 Regulator Genes Proteins 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 125000000539 amino acid group Chemical group 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 208000016063 arterial thoracic outlet syndrome Diseases 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 230000000869 mutational effect Effects 0.000 description 4
- 238000000053 physical method Methods 0.000 description 4
- 230000004983 pleiotropic effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 241000254173 Coleoptera Species 0.000 description 3
- 230000004568 DNA-binding Effects 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241000287828 Gallus gallus Species 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 235000013405 beer Nutrition 0.000 description 3
- 235000013330 chicken meat Nutrition 0.000 description 3
- 238000012364 cultivation method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000011331 genomic analysis Methods 0.000 description 3
- 238000003306 harvesting Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 230000036284 oxygen consumption Effects 0.000 description 3
- 102000054765 polymorphisms of proteins Human genes 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 3
- GRNHLFULJDXJKR-UHFFFAOYSA-N 3-(2-sulfanylethyl)-1h-quinazoline-2,4-dione Chemical compound C1=CC=C2C(=O)N(CCS)C(=O)NC2=C1 GRNHLFULJDXJKR-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 2
- 244000005894 Albizia lebbeck Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 101000709520 Chlamydia trachomatis serovar L2 (strain 434/Bu / ATCC VR-902B) Atypical response regulator protein ChxR Proteins 0.000 description 2
- 241000543381 Cliftonia monophylla Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 244000025361 Ficus carica Species 0.000 description 2
- 235000008730 Ficus carica Nutrition 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 101000636705 Homo sapiens NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial Proteins 0.000 description 2
- 241001446467 Mama Species 0.000 description 2
- 102100031919 NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial Human genes 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001655322 Streptomycetales Species 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 208000027697 autoimmune lymphoproliferative syndrome due to CTLA4 haploinsuffiency Diseases 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 238000010835 comparative analysis Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 108091006104 gene-regulatory proteins Proteins 0.000 description 2
- 102000034356 gene-regulatory proteins Human genes 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229910000358 iron sulfate Inorganic materials 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 229930000044 secondary metabolite Natural products 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 239000000779 smoke Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-N vancomycin Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-N 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- VFXRPXBQCNHQRQ-UHFFFAOYSA-N (alphaR,4R)-Enduracididine Natural products OC(=O)C(N)CC1CNC(=N)N1 VFXRPXBQCNHQRQ-UHFFFAOYSA-N 0.000 description 1
- XNKWTOZWDSBIST-UHFFFAOYSA-N 2-amino-2-(3,5-dichloro-4-hydroxyphenyl)acetic acid Chemical compound OC(=O)C(N)C1=CC(Cl)=C(O)C(Cl)=C1 XNKWTOZWDSBIST-UHFFFAOYSA-N 0.000 description 1
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 1
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- VTIKDEXOEJDMJP-UHFFFAOYSA-N Actinorhodine Natural products CC1OC(CC(=O)O)CC2=C1C(=O)c3c(O)c(cc(O)c3C2=O)c4cc(O)c5C(=O)C6=C(C(C)OC(CC(=O)O)C6)C(=O)c5c4O VTIKDEXOEJDMJP-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 235000010893 Bischofia javanica Nutrition 0.000 description 1
- 240000005220 Bischofia javanica Species 0.000 description 1
- 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 description 1
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- HZZVJAQRINQKSD-UHFFFAOYSA-N Clavulanic acid Natural products OC(=O)C1C(=CCO)OC2CC(=O)N21 HZZVJAQRINQKSD-UHFFFAOYSA-N 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 101000616562 Danio rerio Sonic hedgehog protein A Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 240000003421 Dianthus chinensis Species 0.000 description 1
- 241001649081 Dina Species 0.000 description 1
- 235000017274 Diospyros sandwicensis Nutrition 0.000 description 1
- 101100234002 Drosophila melanogaster Shal gene Proteins 0.000 description 1
- 102000017914 EDNRA Human genes 0.000 description 1
- 101150062404 EDNRA gene Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100021807 ER degradation-enhancing alpha-mannosidase-like protein 1 Human genes 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 101001090612 Escherichia phage Mu Protease I Proteins 0.000 description 1
- 235000014066 European mistletoe Nutrition 0.000 description 1
- 241000975394 Evechinus chloroticus Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 235000002917 Fraxinus ornus Nutrition 0.000 description 1
- 244000182067 Fraxinus ornus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 240000000018 Gnetum gnemon Species 0.000 description 1
- 235000008612 Gnetum gnemon Nutrition 0.000 description 1
- 241000258937 Hemiptera Species 0.000 description 1
- 108010072039 Histidine kinase Proteins 0.000 description 1
- 101000895701 Homo sapiens ER degradation-enhancing alpha-mannosidase-like protein 1 Proteins 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 229910020756 KI—KOH Inorganic materials 0.000 description 1
- 241001397173 Kali <angiosperm> Species 0.000 description 1
- 241001026509 Kata Species 0.000 description 1
- 241000824268 Kuma Species 0.000 description 1
- LJCWONGJFPCTTL-ZETCQYMHSA-N L-4-hydroxyphenylglycine Chemical compound OC(=O)[C@@H](N)C1=CC=C(O)C=C1 LJCWONGJFPCTTL-ZETCQYMHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- VFXRPXBQCNHQRQ-DMTCNVIQSA-N L-enduracididine Chemical compound OC(=O)[C@@H](N)C[C@@H]1CNC(=N)N1 VFXRPXBQCNHQRQ-DMTCNVIQSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 241000282838 Lama Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- 229940110339 Long-acting muscarinic antagonist Drugs 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- MSFSPUZXLOGKHJ-UHFFFAOYSA-N Muraminsaeure Natural products OC(=O)C(C)OC1C(N)C(O)OC(CO)C1O MSFSPUZXLOGKHJ-UHFFFAOYSA-N 0.000 description 1
- 101100236401 Mus musculus Map3k20 gene Proteins 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 241000531207 Oxera splendida Species 0.000 description 1
- 235000016496 Panda oleosa Nutrition 0.000 description 1
- 240000000220 Panda oleosa Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 241001377010 Pila Species 0.000 description 1
- 241001425800 Pipa Species 0.000 description 1
- 102100037681 Protein FEV Human genes 0.000 description 1
- 101710198166 Protein FEV Proteins 0.000 description 1
- 101000796819 Pseudomonas putida Glycerol metabolism activator Proteins 0.000 description 1
- 108090000951 RNA polymerase sigma 70 Proteins 0.000 description 1
- 235000012300 Rhipsalis cassutha Nutrition 0.000 description 1
- 244000152640 Rhipsalis cassutha Species 0.000 description 1
- 235000015076 Shorea robusta Nutrition 0.000 description 1
- 244000166071 Shorea robusta Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- NSFFHOGKXHRQEW-UHFFFAOYSA-N Thiostrepton B Natural products N1C(=O)C(C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(C(C)CC)NC(C(C2=N3)O)C=CC2=C(C(C)O)C=C3C(=O)OC(C)C(C=2SC=C(N=2)C2N=3)NC(=O)C(N=4)=CSC=4C(C(C)(O)C(C)O)NC(=O)C(N=4)CSC=4C(=CC)NC(=O)C(C(C)O)NC(=O)C(N=4)=CSC=4C21CCC=3C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 241000767700 Tyche Species 0.000 description 1
- HIYSWASSDOXZLC-UHFFFAOYSA-N Undecylprodigiosin Natural products CCCCCCCCCCCc1ccc(C=C2N=C(C=C2OC)c2ccc[nH]2)[nH]1 HIYSWASSDOXZLC-UHFFFAOYSA-N 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 206010048010 Withdrawal syndrome Diseases 0.000 description 1
- 241000289690 Xenarthra Species 0.000 description 1
- 101100118936 Xenopus laevis epabp-a gene Proteins 0.000 description 1
- VTIKDEXOEJDMJP-WYUUTHIRSA-N actinorhodin Chemical compound C([C@@H](CC(O)=O)O[C@@H]1C)C(C(C2=C(O)C=3)=O)=C1C(=O)C2=C(O)C=3C(C(=C1C2=O)O)=CC(O)=C1C(=O)C1=C2[C@@H](C)O[C@H](CC(O)=O)C1 VTIKDEXOEJDMJP-WYUUTHIRSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 description 1
- 229950006334 apramycin Drugs 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 210000003578 bacterial chromosome Anatomy 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- YKGYQYOQRGPFTO-UHFFFAOYSA-N bis(8-methylnonyl) hexanedioate Chemical compound CC(C)CCCCCCCOC(=O)CCCCC(=O)OCCCCCCCC(C)C YKGYQYOQRGPFTO-UHFFFAOYSA-N 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- RICLFGYGYQXUFH-UHFFFAOYSA-N buspirone hydrochloride Chemical compound [H+].[Cl-].C1C(=O)N(CCCCN2CCN(CC2)C=2N=CC=CN=2)C(=O)CC21CCCC2 RICLFGYGYQXUFH-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 208000018747 cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome Diseases 0.000 description 1
- MYPYJXKWCTUITO-KIIOPKALSA-N chembl3301825 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)NC)[C@H]1C[C@](C)(N)C(O)[C@H](C)O1 MYPYJXKWCTUITO-KIIOPKALSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- HZZVJAQRINQKSD-PBFISZAISA-N clavulanic acid Chemical compound OC(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 HZZVJAQRINQKSD-PBFISZAISA-N 0.000 description 1
- 229960003324 clavulanic acid Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000001159 dosh Nutrition 0.000 description 1
- 244000245171 dosh Species 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 101150087168 epaC gene Proteins 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 230000008622 extracellular signaling Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 230000004068 intracellular signaling Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 108010051201 lipid I Proteins 0.000 description 1
- 125000003473 lipid group Chemical group 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- PJVMURIFUSQEOU-UHFFFAOYSA-N n-(1,5-dimethyl-3-oxo-2-phenylpyrazol-4-yl)-n-methylnitrous amide Chemical compound O=C1C(N(N=O)C)=C(C)N(C)N1C1=CC=CC=C1 PJVMURIFUSQEOU-UHFFFAOYSA-N 0.000 description 1
- 239000006225 natural substrate Substances 0.000 description 1
- 208000037931 necrotizing enteritis Diseases 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000013587 production medium Substances 0.000 description 1
- 229930182852 proteinogenic amino acid Natural products 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 108091008020 response regulators Proteins 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000037432 silent mutation Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 101150094761 ssaB gene Proteins 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229930188070 thiostrepton Natural products 0.000 description 1
- NSFFHOGKXHRQEW-AIHSUZKVSA-N thiostrepton Chemical compound C([C@]12C=3SC=C(N=3)C(=O)N[C@H](C(=O)NC(/C=3SC[C@@H](N=3)C(=O)N[C@H](C=3SC=C(N=3)C(=O)N[C@H](C=3SC=C(N=3)[C@H]1N=1)[C@@H](C)OC(=O)C3=CC(=C4C=C[C@H]([C@@H](C4=N3)O)N[C@H](C(N[C@@H](C)C(=O)NC(=C)C(=O)N[C@@H](C)C(=O)N2)=O)[C@@H](C)CC)[C@H](C)O)[C@](C)(O)[C@@H](C)O)=C\C)[C@@H](C)O)CC=1C1=NC(C(=O)NC(=C)C(=O)NC(=C)C(N)=O)=CS1 NSFFHOGKXHRQEW-AIHSUZKVSA-N 0.000 description 1
- 229940063214 thiostrepton Drugs 0.000 description 1
- NSFFHOGKXHRQEW-OFMUQYBVSA-N thiostrepton A Natural products CC[C@H](C)[C@@H]1N[C@@H]2C=Cc3c(cc(nc3[C@H]2O)C(=O)O[C@H](C)[C@@H]4NC(=O)c5csc(n5)[C@@H](NC(=O)[C@H]6CSC(=N6)C(=CC)NC(=O)[C@@H](NC(=O)c7csc(n7)[C@]8(CCC(=N[C@@H]8c9csc4n9)c%10nc(cs%10)C(=O)NC(=C)C(=O)NC(=C)C(=O)N)NC(=O)[C@H](C)NC(=O)C(=C)NC(=O)[C@H](C)NC1=O)[C@@H](C)O)[C@](C)(O)[C@@H](C)O)[C@H](C)O NSFFHOGKXHRQEW-OFMUQYBVSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 241001446247 uncultured actinomycete Species 0.000 description 1
- HIYSWASSDOXZLC-HKOYGPOVSA-N undecylprodigiosin Chemical compound N1C(CCCCCCCCCCC)=CC=C1\C=C\1C(OC)=CC(C=2NC=CC=2)=N/1 HIYSWASSDOXZLC-HKOYGPOVSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662430455P | 2016-12-06 | 2016-12-06 | |
| PCT/EP2017/073771 WO2018103905A1 (en) | 2016-12-06 | 2017-09-20 | Modified streptomyces fungicidicus isolates and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA127451C2 true UA127451C2 (uk) | 2023-08-30 |
Family
ID=60043150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201906560A UA127451C2 (uk) | 2016-12-06 | 2017-09-20 | Штам streptomyces fungicidicus для продукування ендурацидину та спосіб одержання ендурацидину |
Country Status (11)
| Country | Link |
|---|---|
| JP (2) | JP2020500509A (ja) |
| CN (1) | CN110072881A (ja) |
| BR (1) | BR112019011603A2 (ja) |
| CO (1) | CO2019005540A2 (ja) |
| MX (1) | MX2019006586A (ja) |
| MY (1) | MY194438A (ja) |
| PE (1) | PE20190967A1 (ja) |
| PH (1) | PH12019501225A1 (ja) |
| TW (1) | TWI770070B (ja) |
| UA (1) | UA127451C2 (ja) |
| WO (1) | WO2018103905A1 (ja) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20191767A1 (es) | 2016-12-06 | 2019-12-17 | Univ Oregon State | Composiciones y metodos para la produccion incrementada de enduracina en una cepa geneticamente modificada de streptomyces fungicidicus |
| CN115261258A (zh) * | 2022-06-07 | 2022-11-01 | 四川汇邦环保科技有限公司 | 一种降解持久霉素的微生物菌剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617881C2 (de) * | 1965-10-13 | 1984-07-05 | Takeda Chemical Industries, Ltd., Osaka | Antibiotikum Enduracidin und seine Herstellung |
| AT269354B (de) * | 1965-10-13 | 1969-03-10 | Takeda Chemical Industries Ltd | Verfahren zur Herstellung eines neuen Antibiotikums |
| US3577530A (en) | 1969-07-24 | 1971-05-04 | Squibb & Sons Inc | Janiemycin |
| JPS6038120B2 (ja) * | 1980-10-31 | 1985-08-30 | 武田薬品工業株式会社 | 抗生物質エンジユラサイジンの製造法 |
| WO2008054945A2 (en) * | 2006-09-29 | 2008-05-08 | State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Enduracidin biosynthetic gene cluster from streptomyces fungicidicus |
| CN101974469B (zh) * | 2010-10-22 | 2012-05-23 | 安徽丰原发酵技术工程研究有限公司 | 一种杀真菌素链霉菌突变菌株及其应用 |
| CN103374537B (zh) * | 2012-04-25 | 2015-01-07 | 牡丹江佰佳信生物科技有限公司 | 一种制备恩拉霉素的方法及其生产菌株 |
| CN102864114B (zh) * | 2012-10-19 | 2013-11-06 | 河北圣雪大成制药有限责任公司 | 一种恩拉霉素高产菌株及其制备方法和应用 |
| CN103740612A (zh) * | 2013-12-19 | 2014-04-23 | 河北圣雪大成制药有限责任公司 | 一种高产恩拉霉素菌株及其筛选方法 |
-
2017
- 2017-09-20 UA UAA201906560A patent/UA127451C2/uk unknown
- 2017-09-20 WO PCT/EP2017/073771 patent/WO2018103905A1/en active Application Filing
- 2017-09-20 BR BR112019011603-6A patent/BR112019011603A2/pt unknown
- 2017-09-20 MX MX2019006586A patent/MX2019006586A/es unknown
- 2017-09-20 MY MYPI2019002918A patent/MY194438A/en unknown
- 2017-09-20 JP JP2019524442A patent/JP2020500509A/ja active Pending
- 2017-09-20 CN CN201780073894.9A patent/CN110072881A/zh active Pending
- 2017-09-20 PE PE2019001065A patent/PE20190967A1/es unknown
- 2017-10-11 TW TW106134804A patent/TWI770070B/zh active
-
2019
- 2019-05-28 CO CONC2019/0005540A patent/CO2019005540A2/es unknown
- 2019-05-31 PH PH12019501225A patent/PH12019501225A1/en unknown
-
2022
- 2022-11-10 JP JP2022180156A patent/JP2023012549A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MY194438A (en) | 2022-11-30 |
| MX2019006586A (es) | 2019-08-22 |
| RU2019117260A3 (ja) | 2021-01-29 |
| PE20190967A1 (es) | 2019-07-08 |
| PH12019501225A1 (en) | 2019-09-23 |
| RU2019117260A (ru) | 2021-01-11 |
| CN110072881A (zh) | 2019-07-30 |
| TWI770070B (zh) | 2022-07-11 |
| JP2020500509A (ja) | 2020-01-16 |
| CO2019005540A2 (es) | 2019-05-31 |
| JP2023012549A (ja) | 2023-01-25 |
| BR112019011603A2 (pt) | 2020-08-18 |
| TW201827590A (zh) | 2018-08-01 |
| WO2018103905A1 (en) | 2018-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA127677C2 (uk) | Мікробна композиція | |
| Dekkers et al. | A two-component system plays an important role in the root-colonizing ability of Pseudomonas fluorescens strain WCS365 | |
| KR101729123B1 (ko) | 경쟁적이고 효과적인 브라디리조븀 자포니쿰 균주 | |
| CA3000621A1 (en) | Use of pectin or pectin-related saccharides to enhance efficacy of plant growth-promoting rhizobacteria (pgpr) strains for promoting growth and health in plants and animals | |
| CN108291219A (zh) | 使用重构nif簇的氮固定 | |
| UA119985C2 (uk) | Мікроорганізм, який виробляє о-фосфосерин, та спосіб отримання о-фосфосерину або l-цистеїну з його застосуванням | |
| CN104837506A (zh) | 免疫调节性小细胞及使用方法 | |
| UA127451C2 (uk) | Штам streptomyces fungicidicus для продукування ендурацидину та спосіб одержання ендурацидину | |
| CN114891678B (zh) | 多粘芽孢杆菌cpl258及其筛选和应用 | |
| AU778146B2 (en) | Biological control of nematodes | |
| KR20210124737A (ko) | 항균활성을 가지는 류코노스톡 락티스 iwm2 균주 | |
| Jing et al. | The small and large subunits of carbamoyl-phosphate synthase exhibit diverse contributions to pathogenicity in Xanthomonas citri subsp. citri | |
| Wang et al. | Genome analysis of Bacillus subtilis JCL16 and the synergistic relationship among its metabolites reveal its potential for biocontrol of Nocardia seriolae | |
| KR102633804B1 (ko) | 재조합 바실러스 속 미생물 및 이를 이용한 모유올리고당 제조방법 | |
| KR101866814B1 (ko) | 뿌리혹선충에 대해 살선충활성을 가지는 자일라리아 그람미카 el 000614 균주 및 이의 용도 | |
| UA127452C2 (uk) | Бактерія streptomyces fungicidicus та спосіб одержання ендурацидину в штамі streptomyces fungicidicus | |
| Weller et al. | Biological control of soil-borne pathogens of wheat: benefits, risks and current challenges | |
| KR102071706B1 (ko) | 박테리오파지 pp2 및 카로신 d를 포함하는 채소 무름병 방제용 조성물 및 이의 용도 | |
| CN105753958A (zh) | 一种新型鱼源抗菌肽突变体及其制备方法和应用 | |
| CN110003318B (zh) | 褐鲳鲉抗菌肽moronecidin及其应用 | |
| CN108912219A (zh) | 拟环纹豹蛛f家族杀虫基因及其编码的成熟肽与应用 | |
| CN110078812A (zh) | 多肽imb-m2的异源表达及其在增强nk细胞杀瘤活性中的应用 | |
| JPH0687716A (ja) | イネ苗立枯細菌病の防除方法 | |
| CN111748025B (zh) | 一种褐鲳鲉抗菌肽leap2及其应用 | |
| RU2773311C2 (ru) | Модифицированные изоляты streptomyces fungicidicus и их применение |